SB 271·DE·senate
AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO PHARMACY BENEFITS MANAGERS.
Signed into LawFiled Mar 26, 2026
Sponsor: Dave Sokola (D)
Latest Action
Signed
Sep 10, 2026
Summary
The act adds new definitions, sets uniform audit notice requirements, expands pharmacy appeal rights, bans retaliation for lawful disclosures, and imposes notice and reporting limits on pharmacy benefit managers (PBMs). It applies to PBM‑pharmacy contracts entered into after Dec. 31, 2026 and aims to increase transparency and protect pharmacies and consumers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 271 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 271 freeOr ask your AI assistant about SB 271 directly:
Add to Claude, ChatGPT or Cursor